Pharmaceutical Industry Information Portal

HomeTagsOmicron

All posts by tag

Omicron

Omicron-specific vaccine candidates containing inactivated or “killed” coronaviruses approved for clinical trials

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong,...

RedHill reports powerful inhibition of Omicron SARS-CoV-2 variant by the oral drug candidate

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for hospitalized patients with moderate to...

Roche offers molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants

Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate...

WHO: COVID-19 vaccines in the context of the circulation of the Omicron

The World Health Organization, with the support of the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), continues to review and assess the public...

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we have throughout the COVID-19 pandemic,...

Moderna aims to roll out a combined flu and COVID vaccine in 2023

The biotechnological company Moderna is working to create a single shot vaccine against both flu and coronavirus by autumn 2023, Moderna's Chief Executive Officer...
spot_img

Expert Articles

spot_img